Oral Dissolving Strip vs Powder Sachet: Dose Control

By Jack Zheng, MS Pharmacy — Founder of MIHIYO Labs

Summary

An oral dissolving strip and a powder sachet deliver a dose in very different ways. A powder sachet must be measured or emptied into a set volume of water, mixed, and swallowed, so its accuracy depends on the user; in one 2024 study, hand-scooping powder carried about twice the measurement error of measuring water (9.0 percent versus 4.5 percent). An oral dissolving strip (ODS) is a fixed unit dose that dissolves on the tongue without water and presents part of the dose to the oral mucosa. For MIHIYO Labs, that makes the ODS the better choice when portability, repeatable dosing, and water-free use matter most.

Is an oral dissolving strip better than a powder sachet?

For travel, repeatable dosing, and water-free use, yes. The comparison of an oral dissolving strip vs powder sachet really comes down to one question: how much of the work is the format doing, and how much is the user doing? An oral dissolving strip (ODS) is a thin polymer film that carries a fixed dose and dissolves on the tongue in seconds without water.¹ A powder sachet hands part of the job back to the person — measure it, or empty it into the right volume of liquid, mix it, and drink it. Each of those steps is a place where the delivered dose can drift away from the labeled dose.

That is the design lens I keep coming back to. When I formulate a strip, the dose is locked into the film before the customer ever opens the pouch. A scoop or a sachet poured into a glass cannot make that promise, because the final concentration depends on how much water went in and how fully the powder dissolved.

Why does a powder sachet's dose depend on the person using it?

A powder sachet's delivered dose depends on the user because reconstitution is a manual step, and manual steps vary. A sachet of powder is not a finished dose until someone adds the correct amount of water and mixes it fully. Two things can go wrong: the powder can be mis-measured (for multi-dose tubs and scoops), and the water volume can be wrong (for single-sachet reconstitution). Both shift the concentration the person actually swallows.

The measurement error is real and quantified. In a 2024 experimental study of 84 caregivers, hand-scooping infant formula powder produced a mean absolute error of 9.0 percent, roughly twice the 4.5 percent error seen when the same people measured water; about a quarter of powder measurements were off by 10 percent or more (Rosenkranz et al., 2024).² Powder is harder to measure than liquid because scoop packing, compaction, and leveling all change how many grams land in the scoop.

Even when the powder is pre-portioned in a single sachet, the water step still introduces error. In a 2022 consumer study, 120 people in Bengaluru and Pune prepared oral rehydration salts (ORS) from standard sachets at home; only 14 percent produced a solution in the intended reduced-osmolarity range, while 43 percent came out above 310 mOsmol/kg — too concentrated — because of how much water they used (Redkar et al., 2022).³ ORS is a forgiving public-health product with wide instructions, and people still missed the target most of the time. A precise low-dose supplement is less forgiving, not more.

The measuring tools themselves add error. When researchers tested the devices that come with reconstituted oral medicines, an oral syringe measured to within about 3 to 5 percent of target, but opaque dosing spoons under-dosed by 24 to 31 percent and marked spoons over-dosed by a similar margin (Neves and Auxtero, 2021).⁴ The lesson generalizes: the more a dosage form leans on a household tool and a manual step, the wider the delivered-dose distribution.

An oral dissolving strip removes that distribution. Bioavailability is the fraction of a dose that reaches the bloodstream unchanged, and you cannot have a consistent bioavailability if the dose itself is inconsistent. A unit-dose film fixes the amount of active in the matrix during manufacturing, so the variable that powders leave to the user is closed before the product ships.¹

How do the two formats compare on dose, water, and travel?

Across the four dimensions that matter most for a portable supplement — dose control, water requirement, portability, and absorption route — an oral dissolving strip and a powder sachet make opposite trade-offs. The table below is the spine; the pharmacology behind each row follows.

Dose control. This is the powder format's structural weakness and the film's structural strength. A sachet is finished by the user; a film is finished in the factory. The 9.0 percent versus 4.5 percent powder-vs-water error gap (Rosenkranz et al., 2024) and the 24 to 31 percent spoon errors (Neves and Auxtero, 2021) are not edge cases — they are what happens when ordinary people do a manual step. A film moves that step off the kitchen counter and into a controlled process.¹²⁴

Water requirement. A powder sachet is, by definition, a concentrate that needs a solvent. The Redkar study shows how much that solvent step moves the result: most home-prepared ORS solutions missed the target osmolarity because the water volume was wrong (Redkar et al., 2022).³ An oral thin film needs no water at all — it disperses in saliva within seconds, which is exactly why films are described as usable when access to water is not possible, such as during travel (Şevinç Özakar and Özakar, 2021).¹

Portability. A sachet is light, but it is not self-contained: to use one you also need a clean cup, drinkable water, and time to mix. A film is a sealed, stamp-sized unit you can use in a meeting, on a plane, or mid-hike with nothing else in hand.¹ For a grab-and-go supplement, that difference is the whole point.

What changes about absorption when a strip dissolves on the tongue?

When a strip dissolves on the tongue, part of the dose can cross the oral mucosa directly into the bloodstream, skipping the first-pass liver metabolism that a swallowed powder solution cannot avoid. First-pass metabolism is the fraction of an oral dose broken down by the gut wall and liver before it reaches systemic circulation. A reconstituted powder is swallowed, so it takes the full gastrointestinal route; oral thin films are noted for enhanced systemic bioavailability precisely because the oral-mucosal route bypasses that first pass (Şevinç Özakar and Özakar, 2021).¹

The size of that gain depends on how long the dose stays in contact with the mucosa. In a 2021 study of microdosed midazolam, absolute bioavailability rose from 27.8 percent when the dose was swallowed as a drinking solution to 66.1 percent after 100 seconds of buccal contact (Grass et al., 2021).⁵ In a related buccal-film study, the film delivered about 1.15 times the peak concentration and 1.16 to 1.19 times the total exposure of the same drug given as a swallowed solution (Kiene et al., 2019).⁶ These studies were run on midazolam in research settings, not on any MIHIYO product, but the mechanism is general: holding a dose against the oral lining changes how much survives.

A powder sachet has no mechanism to do this. By the time the solution is mixed and swallowed, contact with the oral mucosa is incidental and brief. That does not make powders bad — it makes them a gut-route format, which is the right answer for high-dose or bulk actives and the wrong answer when the goal is a small, fast, mucosa-first dose.

What this means for MIHIYO products

For a low-dose, fast-acting active like the caffeine and L-theanine in the Energy + Focus ODS, the film format closes the two gaps a powder leaves open: the dose is fixed, and part of it can be absorbed across the oral mucosa rather than waiting on gut transit. A scoop of energy powder in a shaker bottle is convenient at a desk, but its delivered dose depends on the scoop and the water, and all of it goes through the gut.

The design decision I make for these products is to treat the unit dose as non-negotiable. I would rather constrain the payload — a film can only carry so much active per strip — than hand dose accuracy back to the user with a scoop. That is the honest trade-off: a powder sachet can carry far more material per serving, and for a creatine or protein dose that capacity wins. For a precise low-dose stimulant or a sleep active where a few milligrams matter, the fixed-dose, water-free film is the cleaner tool. The same logic runs through the ODS vs capsule and ODS vs tablet comparisons in this series.

Where the strip format falls short

An oral dissolving strip is not the right answer for every supplement, and the limits are about load and mucosal reality. A film carries a small amount of active per unit; a powder sachet can deliver grams. If your dose is large — electrolytes, fiber, protein, creatine — a sachet is the sensible format and a strip is not. Trying to force a high payload into a film makes it thick, slow to dissolve, and unpleasant.

The mucosal-absorption advantage is also partial, not total. Saliva washes some of the dissolved active toward the throat, where it is swallowed and takes the ordinary gut route anyway, and the gain depends on contact time (Grass et al., 2021).⁵ A strip improves the dosing and the route for a fraction of the dose; it does not turn every milligram into a sublingual injection. And a powder solution has one genuine edge: it is easy to sip slowly, which can be gentler on the stomach for some people than a concentrated bolus. Honest formulation means naming where the other format wins.

The bottom line

In the oral dissolving strip vs powder sachet comparison, the strip wins on dose control, water-free convenience, and portability, while the sachet wins on payload capacity. A powder sachet leaves the final dose to the user's scoop and water volume — a step that introduces roughly 9 percent error for hand-scooped powder and pushed most home-prepared solutions off target in real-world studies. An oral dissolving strip fixes the dose in the film and dissolves on the tongue with no water, presenting part of the dose to the oral mucosa. At MIHIYO Labs, that is why we reach for a film whenever the active is small, fast, and meant to be taken anywhere — and why we would still point you to a sachet when the dose is large.

References

1. Şevinç Özakar R, Özakar E. Current Overview of Oral Thin Films. Turkish Journal of Pharmaceutical Sciences. 2021;18(1):111-121. PMID: 33634686. DOI: 10.4274/tjps.galenos.2020.76390. https://pubmed.ncbi.nlm.nih.gov/33634686/
2. Rosenkranz RR, Gonzalez-Alvarez A, Acosta C, et al. Variability and error in measurement of infant formula powder and water: an experimental study. Frontiers in Nutrition. 2024;11:1385496. DOI: 10.3389/fnut.2024.1385496. https://www.frontiersin.org/articles/10.3389/fnut.2024.1385496/full
3. Redkar M, Spegel C, Tesado C, et al. Wide variability in osmolality of reconstituted powdered oral rehydration salts due to disparity in the method of preparation among Indian consumers. Journal of Applied Pharmaceutical Science. 2022;12(6):224-229. https://japsonline.com/abstract.php?article_id=3678&sts=2
4. Neves I, Auxtero MD. Dosing Accuracy of Oral Extemporaneous Suspensions of Antibiotics: Measuring Procedures and Administration Devices. Pharmaceutics. 2021;13(4):528. PMID: 33920192. DOI: 10.3390/pharmaceutics13040528. https://pubmed.ncbi.nlm.nih.gov/33920192/
5. Grass J, Rose P, Burhenne J, et al. Absolute Bioavailability of Microdosed Midazolam After Buccal Administration Is Dependent on Buccal Exposure Time. The Journal of Clinical Pharmacology. 2021;61(4):472-479. PMID: 32976642. DOI: 10.1002/jcph.1751. https://pubmed.ncbi.nlm.nih.gov/32976642/
6. Kiene K, Hayasi N, Burhenne J, et al. Microdosed midazolam for the determination of cytochrome P450 3A activity: Development and clinical evaluation of a buccal film. European Journal of Pharmaceutical Sciences. 2019;135:77-82. PMID: 31102650. DOI: 10.1016/j.ejps.2019.05.010. https://pubmed.ncbi.nlm.nih.gov/31102650/

By Jack Zheng, MS Pharmacy — Founder of MIHIYO Labs. Focused on the R&D of high-bioavailability, fast-absorption oral dissolving strips.